In addition, clinical studies have shown that Per2 expression is reduced in cancer patients, and it plays a tumour suppressor role in breast cancer, skin tumours, hepatocellular carcinoma, colorectal cancer and head and neck squamous cell carcinoma15, 16, 17, 18, 19. This evidence concerns the gene PER2 and cancer.